Due to the lack of efficient therapeutics for MPNST and the potential link between loss of function of neurofibromin, RAS signalling and TRAIL sensitivity, we were interested in evaluating the effects of TRAIL on MPNST cells. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.